Newsroom

Latest News

Business
30 October 2017

The Race goes on

Business
30 October 2017

Alvogen Day around the world

Business
05 October 2017

Alvogen obtains first approval for glatiramer acetate 40 mg/mL in Europe

Business
19 September 2017

Alvogen wins international branding awards

Business
18 September 2017

Alvogen’s senior management team gathers in Iceland for annual Kick-off meeting

Business
11 September 2017

Alvogen subsidiary confirms ANDA filing and patent challenge for generic Revlimid®

Business
06 September 2017

Alvogen adds Qsymia to its anti-obesity portfolio in Korea

Business
15 August 2017

Alvogen announces acquisition to expand Russian business

Business
16 June 2017

And the winner is … Alvogen again!

Business
08 February 2017

Are you our next partner?

Business
06 February 2017

Global kick-off in Malta

Business
12 December 2016

Alvogen launches the first generic equivalent to Tamiflu® capsules in the United States

Business
01 December 2016

Alvogen acquires leading nasal spray device in Russia

Business
14 October 2016

Alvogen scores in Barcelona

Business
05 September 2016

Alvogen launches first generic equivalent of Copaxone(TM) in Europe

Business
18 August 2016

Alvogen warming up for CPhI 2016 in Barcelona

Charity
13 June 2016

Color Run more colorful than ever!

Business
08 June 2016

Alvotech opens state-of-the-art biosimilar facility in Iceland

Business
04 May 2016

Alvogen launches first generic equivalent of zoladex

Business
12 April 2016

Alvogen CEO Robert Wessman visits Maltese office

Business
05 April 2016

Alvogen in Harvard case study

Media contact

Elisabet Hjaltadottir

Corporate Marketing & Communication